Boston Biomedical Research Institute

Array

Ms. Donna Cohen concentrates her practice in the area of business, landlord tenant and real estate related litigation and commercial leasing. She actively volunteers at the Boston Housing Court Lawyer for a Day project sponsored by the Boston Bar Association. Previously, Ms. Cohen served as a faculty/lecturer for the landlord/tenant section of the Massachusetts Academy of Trial Attorneys. As faculty member she also authored several articles on landlord tenant law as well as creating the Academy's manual for City of Boston Housing Evictions during the period of rent control. She is a contributing author to the Thomson-West Massachusetts Practices series, Landlord-Tenant Law (Warshaw, G). Ms. Cohen, in conjunction with the Suffolk University Law School established the Moot Court Program for sixth graders at the Dana Hall School in Wellesley, Massachusetts. She is a former trustee and co-chair of the Dual Challenge Campaign of the Boston Biomedical Research Institute, an independent research institute dedicated to basic biomedical research. She currently serves as a consultant to Women & Money, LLC, an organization formed to educate women on issues of money and financial independence. She has been listed in Who's Who of Practicing Attorneys, Who's Who of American Women as well as the International Who's Who of Professional and Business Women for significant career achievements and contributions to society. Ms. Cohen received her BS in Communication Studies from the University of Massachusetts, Amherst. While at the University of Massachusetts she served as Chief Justice of the Student Court. Ms. Cohen received her Juris Doctor from Suffolk University School of Law. While at Suffolk University Law School she served as Vice President of the Student Chapter of American Trial Lawyers Association and received the Thomas C. Clark Competition Best Brief Award.

Keith D. Crawford M.D., Ph.D. is a member of the faculty of Harvard Medical School and Brigham and Women's Hospital since 1997, where he is the director of the Laboratory of Molecular Diagnostics (LMD) and the assistant directors of the Laboratory of Innovative Translational Technologies at the Harvard School of Dental Medicine and the DOD funded Advance Medical Countermeasure Consortium. In addition, Dr. Crawford is on the board of Global Security Management (GSM), Parcell Labs, and Boston Biomedical Research Institute, where he serves as the healthcare technologies specialist. In addition to his board position on GSM, he is responsible for identifying and developing healthcare-related business opportunities for GSH in the US, China, Middle East, and Africa.

Brill Neumann Associates specializes in consulting and executive search for the country's leading colleges and universities, economic and community development initiatives, and health care organizations.

Mr. Palladino has held in executive positions with leading public and private healthcare and biotechnology companies. Most recently, he served as COO and CFO of medical device maker Microsulis, a 3i portfolio company. He also served as Executive Vice President and Chief Financial Officer of BioSphere Medical (NASDQ: BSMD) where he led equity offerings that raised over $60 million. In 1999, as CFO of Coretek, Inc., Mr. Palladino raised $20 million in private funding and oversaw sale of the company to Nortel. From the mid-1980a s through the 1990a s he held executive positions at three public companies where his responsibilities included operations management, mergers and acquisitions, financings, and strategic planning. Mr. Palladino earned an MBA in Entrepreneurial Studies and Finance from Babson College. He serves on the audit committee of Boston Biomedical Research Institute, Chairs the Advisory Committee of MedStart Solutions, Inc., and is a member of the MIT Enterprise Forum.